Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy

被引:9
|
作者
Kang, Yuqi
Xu, Boyang
Shi, Sufang
Zhou, Xujie
Chen, Pei
Liu, Lijun
Li, Yebei
Leng, Yueqi
Lv, Jicheng
Zhu, Li
Zhang, Hong
机构
[1] Peking Univ First Hosp, Renal Div, Dept Med, Beijing, Peoples R China
[2] Peking Univ, Inst Nephrol, Beijing, Peoples R China
[3] Peking Univ, Key Lab Renal Dis, Beijing, Peoples R China
[4] Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Natl Hlth Commiss, Beijing, Peoples R China
[5] Peking Univ, State Key Lab Vasc Homeostasis & Remodeling, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
complement; IgA nephropathy; immune complexes; outcome; progression of renal failures; GLOMERULAR-DISEASES; FACTOR-H; CFHR1; CHINESE; ECULIZUMAB; ACTIVATION; PROTEINS; DELETION; GENES; RISK;
D O I
10.2215/CJN.0000000000000290
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background IgA nephropathy is the most common primary GN worldwide, with dominant deposition of IgA and co-deposits of complement component 3 (C3). Phenotypes and progression of IgA nephropathy varies among different ethnic populations, while patients with IgA nephropathy from Asia showed more severe clinical phenotypes, active kidney lesions, and rapid progression. Our previous genome-wide association study identified complement factor H (CFH) variant rs6677604, tightly linked with the deletion of CFH-related protein 3 and CFH-related protein 1 genes (DCFHR3-1), as IgA nephropathy susceptible variant, and additionally revealed its effect on complement regulation in IgA nephropathy. Methods To further explore the effect of rs6677604 on IgA nephropathy progression, here we enrolled a Chinese IgA nephropathy cohort of 1781 patients with regular follow-up for analysis. The rs6677604 genotype was measured, and the genotype-phenotype correlation was analyzed using the t test, the chi-squared test, or the nonparametric test, and the association between rs6677604 genotype or mesangial C3 deposition and IgA nephropathy prognosis was analyzed using Kaplan-Meier analysis and Cox regression. Results We found that patients with rs6677604-GG genotype had a stronger intensity of mesangial C3 deposition than those with the rs6677604-AA/AG genotype. Patients with IgA nephropathy who had stronger intensity of C3 deposition manifested with more severe clinical and pathological manifestations, including lower eGFR and higher Oxford-M/S/T/C (mesangial hypercellularity, endocapillary cellularity, segmental sclerosis, interstitial fibrosis/tubular atrophy, and crescent) scores. In the survival analysis, stronger intensity of mesangial C3 deposition, but not rs6677604-GG genotypes, was associated with poor long-term kidney outcome in IgA nephropathy. Conclusions We found that in Chinese patients with IgA nephropathy, variant rs6677604 was associated with mesangial C3 deposition, and mesangial C3 deposition, but not rs6677604, was associated with IgA nephropathy severity and progression.
引用
收藏
页码:1583 / 1591
页数:9
相关论文
共 50 条
  • [31] Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy
    Kawasaki, Yukihiko
    Maeda, Ryo
    Ohara, Shinichiro
    Suyama, Kazuhide
    Hosoya, Mitsuaki
    PEDIATRICS INTERNATIONAL, 2018, 60 (02) : 162 - 167
  • [32] Histological reappraisal of IgA nephropathy: the role of glomerular pattern of injury and mesangial complement deposition
    Obrisca, Bogdan
    Mocanu, Valentin
    Jurubita, Roxana
    Vrabie, Alexandra
    Berechet, Andreea
    Lujinschi, Stefan
    Sorohan, Bogdan
    Andronesi, Andreea
    Achim, Camelia
    Lupusoru, Gabriela
    Micu, Georgia
    Caceaune, Nicu
    Gherghiceanu, Mihaela
    Ismail, Gener
    BMC NEPHROLOGY, 2024, 25 (01)
  • [33] Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy
    Chen, Pei
    Yu, Guizhen
    Zhang, Xue
    Xie, Xinfang
    Wang, Jinwei
    Shi, Sufang
    Liu, Lijun
    Lv, Jicheng
    Zhang, Hong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1458 - 1465
  • [34] Plasma galactose-deficient IgA1 and C3 and CKD Progression in IgA nephropathy
    Yu, G. -Z.
    Chen, P.
    Zhang, X.
    Shi, S. -F.
    Lv, J. -C.
    Zhang, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 916 - 916
  • [35] Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy
    Ji, Feng Ping
    Wen, Lu
    Zhang, Yan Ping
    Liu, Er Peng
    Wen, Jian Guo
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1287 - 1294
  • [36] Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy
    Feng Ping Ji
    Lu Wen
    Yan Ping Zhang
    Er Peng Liu
    Jian Guo Wen
    International Urology and Nephrology, 2022, 54 : 1287 - 1294
  • [37] Activated complement C3 (actC3): A novel predictor of progressive IgA-nephropathy.
    Floege, J
    Burg, M
    Brunkhorst, R
    Schulze, M
    Gotze, O
    Koch, KM
    Zwirner, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0435 - A0435
  • [38] Mesangial C1q Deposition in IgA Nephropathy: Does the Classical Complement Pathway Play an Independent Role?
    Gaggero, Gabriele
    Mazzocco, Katia
    Cafferata, Barbara
    Angeletti, Andrea
    INDIAN JOURNAL OF NEPHROLOGY, 2025, 35 (01) : 116 - 117
  • [39] Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy
    Torikoshi, Kazuo
    Endo, Tomomi
    Tsukamoto, Tatsuo
    Yasuda, Takashi
    Yasuda, Yoshinari
    Kawamura, Tetsuya
    Matsuo, Seiichi
    Suzuki, Yusuke
    Muso, Eri
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (10) : 3389 - 3396
  • [40] Aberrant O-glycosylation of IgA1 and complement in IgA nephropathy: Glomerular immunodeposits of patients with histologically active disease exhibit elevated colocalization of IgA and complement C3
    Novak, Lea
    Hall, Stacy D.
    Gurganus, Graham L.
    Rizk, Dana V.
    Julian, Bruce A.
    Haas, Mark
    Novak, Jan
    GLYCOBIOLOGY, 2023, 33 (11) : 1002 - 1003